Pioneering cancer gene therapy by Novartis backed by U.S. panel
Read More
Bagikan Berita Ini
Rabu, 12 Juli 2017
News Business
Pioneering cancer gene therapy by Novartis backed by U.S. panel
(Reuters) - Novartis AG's pioneering cancer drug won the backing of a federal advisory panel on Wednesday, paving the way for the first gene therapy to be approved in the United States.
Pioneering cancer gene therapy by Novartis backed by U.S. panel
Read More
Bagikan Berita Ini
Pioneering cancer gene therapy by Novartis backed by U.S. panel
Read More
Bagikan Berita Ini
0 Response to "Pioneering cancer gene therapy by Novartis backed by U.S. panel"
Posting Komentar